YOLFTbeta
30

Liaoning He Eye Hospital Group Co. LTD.

301103 · SHE · Healthcare / Medical Care Facilities

15.73CNY-0.23 (-1.44%)

Price History

Full chart

Market Stats

Previous Close15.96
Open15.82
Day Range15.65 – 16.18
52-Week Range14.50 – 22.34
Volume1.71M
Market Cap2.69B
P/E (TTM)106.44
Forward P/E0.00
EPS0.16
Dividend Yield0.88%
Beta0.54
50-Day Avg16.34
200-Day Avg18.45

About

Liaoning He Eye Hospital Group Co., LTD., together with its subsidiaries, provides ophthalmological and optometry services to patients with eye diseases in China. The company offers treatment for common blinding eye diseases, including cataracts, glaucoma, and vitreoretinal disorders; specialized treatments, such as dry eye and traditional Chinese medicine; and optometry services, including optical correction, refractive surgery, and vision training for refractive errors. It also provides vitreoretinal diagnosis and treatment services, non-surgical and cataract treatment, and other eye disease diagnosis and treatment services; and cataract surgery, refractive error correction surgery, vitreoretinal surgery, and other surgical procedures. In addition, the company offers refractive cataracts, LASIK surgery, myopia prevention, medical fitting, diabetic retinopathy, dry eyes and cornea, gene diagnosis, and comprehensive eye disease solutions. Further, it engages in the sale and testing of medical devices; wholesale of optometry products; business and technical services; technology development, consulting, promotion, and application; import and export trade; wholesale business; and health and social work activities. Liaoning He Eye Hospital Group Co., LTD. was founded in 1995 and is based in Shenyang, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Wei He
  • Employees3.17K
  • HeadquartersJiataihe International Building, Shenyang, China, 110034, China
  • Websitehttps://www.hsyk.com.cn

Leadership

  • Mr. Wei HeChairman of the Board & Acting Board Secretary · b. 1960
  • Mr. Yuehua HeCFO & Financial Director · b. 1978
  • Ms. Ling XuDeputy General Manager · b. 1977
  • Mr. Chun Hui ZhengDeputy General Manager · b. 1978
  • Yanming WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue745.56M838.47M962.45M955.31M1.19B1.10B1.09B
Growth (%)-+12.46%+14.79%-0.74%+24.07%-7.56%-0.28%
Cost of Revenue423.43M474.30M574.54M588.47M690.28M672.65M644.79M
Gross Profit322.13M364.18M387.91M366.85M494.95M422.99M447.83M
Gross Margin43.21%43.43%40.30%38.40%41.76%38.61%40.99%
Operating Expense215.53M222.50M252.29M303.26M406.67M424.09M397.45M
Operating Income106.60M141.67M135.62M63.59M88.27M-1.11M50.38M
Operating Margin14.30%16.90%14.09%6.66%7.45%-0.10%4.61%
EBITDA171.19M187.16M259.13M188.80M229.66M124.66M167.66M
EBITDA Margin22.96%22.32%26.92%19.76%19.38%11.38%15.34%
Net Income80.60M100.24M86.36M32.59M63.55M-27.40M27.34M
Net Income Margin10.81%11.95%8.97%3.41%5.36%-2.50%2.50%
R&D1.61M1.60M1.23M1.26M12.62M18.11M16.28M
R&D as % of Total Revenue0.22%0.19%0.13%0.13%1.07%1.65%1.49%
Interest Expense3.84M640.00K11.46M12.18M13.60M11.34M8.77M
Interest Expense % of Total Revenue0.52%0.08%1.19%1.28%1.15%1.03%0.80%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets989.36M1.35B1.42B2.61B2.48B2.23B2.18B
Total Liabilities127.67M387.72M371.48M430.24M411.36M345.71M297.47M
Total Equity861.70M963.29M1.05B2.17B2.08B1.88B1.88B
Cash542.85M613.37M698.51M1.64B1.59B767.32M541.91M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow120.40M169.74M213.61M147.98M176.77M155.65M156.93M
Capital Expenditure111.46M93.16M71.22M49.11M188.51M116.33M33.75M
Free Cash Flow8.94M76.58M142.38M98.87M-11.74M39.31M123.19M
Dividends Paid---72.94M158.03M93.97M23.30M
FCF to OCF7.42%45.12%66.66%66.81%-6.64%25.26%78.49%
Dividend Paid to FCF---73.77%-1346.50%239.01%18.91%

Earnings

Report DateMar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------
EPS Actual0.170.100.15-0.210.360.140.13-0.230.18-0.03-0.05-0.280.210.080.06-0.170.210.06
Surprise------------------
Timing------------------

Key Statistics & Ratios

Market Cap2.69B
Enterprise Value1.44B
Trailing P/E106.44
Forward P/E0.00
Price / Sales2.41
Price / Book1.37
EPS0.16
Book Value12.30
Revenue (TTM)1.12B
Gross Profit (TTM)464.23M
EBITDA89.62M
Profit Margin2.20%
Operating Margin3.65%
Return on Equity1.27%
Return on Assets1.21%
Shares Outstanding158.03M
Shares Float58.91M
Beta0.54
Dividend Yield0.88%
Dividend Rate0.15
Payout Ratio94.88%

Dividends

20261×
0.15May 29, 2026
20251×
0.15Jun 3, 2025
20241×
0.61Jul 5, 2024
20231×
1.00May 29, 2023
20221×
0.60Jun 1, 2022

Stock Splits

  • Jun 1, 20221.3:1